Influence of corevalve revalving system implantation on mitral valve function: An Echocardiographic Study in Selected Patients

Benedetta De Chiara; Antonella Moreo; Federico De Marco; Francesco Musca; Jacopo Oreglia; Elisabetta Lobiati; Giuseppe Bruschi; Oriana Belli; Francesco Mauri; Silvio Klugmann

doi:10.1002/ccd.23045

Influence of corevalve revalving system implantation on mitral valve function: An Echocardiographic Study in Selected Patients

Benedetta De Chiara, Antonella Moreo, Federico De Marco, Francesco Musca, Jacopo Oreglia, Elisabetta Lobiati, Giuseppe Bruschi, Oriana Belli, Francesco Mauri, Silvio Klugmann

IRCCS Policlinico San Donato

Research output: Contribution to journal › Article

Abstract

Objectives: The purpose of this study is to verify whether transcatheter aortic valve implantation (TAVI) determined changes in mitral valve (MV) function, in terms of mitral regurgitation (MR) and stenosis. Background: Little data is available regarding the effects of TAVI on global MV function, often derived from analysis primarily focused on clinical and aortic related outcomes. Methods: From May 2008 to March 2010, 73 patients with severe symptomatic aortic stenosis underwent TAVI with the CoreValve ReValving System. The study population consisted of 58 patients (27 males, mean age 82 ± 7 years) who underwent transthoracic echocardiography at least ≥1 month after implantation (mean follow-up 7.8 ± 5.4 months). Results: In patients with a left ventricular dysfunction (ejection fraction, EF,

Original language	English
Pages (from-to)	638-644
Number of pages	7
Journal	Catheterization and Cardiovascular Interventions
Volume	78
Issue number	4
DOIs	https://doi.org/10.1002/ccd.23045
Publication status	Published - Oct 3 2011

Fingerprint

Keywords

CoreValve ReValving system
implantation depth
mitral regurgitation

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

Cite this

De Chiara, B., Moreo, A., De Marco, F., Musca, F., Oreglia, J., Lobiati, E., Bruschi, G., Belli, O., Mauri, F., & Klugmann, S. (2011). Influence of corevalve revalving system implantation on mitral valve function: An Echocardiographic Study in Selected Patients. Catheterization and Cardiovascular Interventions, 78(4), 638-644. https://doi.org/10.1002/ccd.23045

Influence of corevalve revalving system implantation on mitral valve function : An Echocardiographic Study in Selected Patients. / De Chiara, Benedetta; Moreo, Antonella; De Marco, Federico; Musca, Francesco; Oreglia, Jacopo; Lobiati, Elisabetta; Bruschi, Giuseppe; Belli, Oriana; Mauri, Francesco; Klugmann, Silvio.

In: Catheterization and Cardiovascular Interventions, Vol. 78, No. 4, 03.10.2011, p. 638-644.

Research output: Contribution to journal › Article

De Chiara, Benedetta ; Moreo, Antonella ; De Marco, Federico ; Musca, Francesco ; Oreglia, Jacopo ; Lobiati, Elisabetta ; Bruschi, Giuseppe ; Belli, Oriana ; Mauri, Francesco ; Klugmann, Silvio. / Influence of corevalve revalving system implantation on mitral valve function : An Echocardiographic Study in Selected Patients. In: Catheterization and Cardiovascular Interventions. 2011 ; Vol. 78, No. 4. pp. 638-644.

@article{a40b109122884aa9877be34b355f50fa,

title = "Influence of corevalve revalving system implantation on mitral valve function: An Echocardiographic Study in Selected Patients",

abstract = "Objectives: The purpose of this study is to verify whether transcatheter aortic valve implantation (TAVI) determined changes in mitral valve (MV) function, in terms of mitral regurgitation (MR) and stenosis. Background: Little data is available regarding the effects of TAVI on global MV function, often derived from analysis primarily focused on clinical and aortic related outcomes. Methods: From May 2008 to March 2010, 73 patients with severe symptomatic aortic stenosis underwent TAVI with the CoreValve ReValving System. The study population consisted of 58 patients (27 males, mean age 82 ± 7 years) who underwent transthoracic echocardiography at least ≥1 month after implantation (mean follow-up 7.8 ± 5.4 months). Results: In patients with a left ventricular dysfunction (ejection fraction, EF, ",

keywords = "CoreValve ReValving system, implantation depth, mitral regurgitation",

author = "{De Chiara}, Benedetta and Antonella Moreo and {De Marco}, Federico and Francesco Musca and Jacopo Oreglia and Elisabetta Lobiati and Giuseppe Bruschi and Oriana Belli and Francesco Mauri and Silvio Klugmann",

year = "2011",

month = oct

day = "3",

doi = "10.1002/ccd.23045",

language = "English",

volume = "78",

pages = "638--644",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Influence of corevalve revalving system implantation on mitral valve function

T2 - An Echocardiographic Study in Selected Patients

AU - De Chiara, Benedetta

AU - Moreo, Antonella

AU - De Marco, Federico

AU - Musca, Francesco

AU - Oreglia, Jacopo

AU - Lobiati, Elisabetta

AU - Bruschi, Giuseppe

AU - Belli, Oriana

AU - Mauri, Francesco

AU - Klugmann, Silvio

PY - 2011/10/3

Y1 - 2011/10/3

N2 - Objectives: The purpose of this study is to verify whether transcatheter aortic valve implantation (TAVI) determined changes in mitral valve (MV) function, in terms of mitral regurgitation (MR) and stenosis. Background: Little data is available regarding the effects of TAVI on global MV function, often derived from analysis primarily focused on clinical and aortic related outcomes. Methods: From May 2008 to March 2010, 73 patients with severe symptomatic aortic stenosis underwent TAVI with the CoreValve ReValving System. The study population consisted of 58 patients (27 males, mean age 82 ± 7 years) who underwent transthoracic echocardiography at least ≥1 month after implantation (mean follow-up 7.8 ± 5.4 months). Results: In patients with a left ventricular dysfunction (ejection fraction, EF,

AB - Objectives: The purpose of this study is to verify whether transcatheter aortic valve implantation (TAVI) determined changes in mitral valve (MV) function, in terms of mitral regurgitation (MR) and stenosis. Background: Little data is available regarding the effects of TAVI on global MV function, often derived from analysis primarily focused on clinical and aortic related outcomes. Methods: From May 2008 to March 2010, 73 patients with severe symptomatic aortic stenosis underwent TAVI with the CoreValve ReValving System. The study population consisted of 58 patients (27 males, mean age 82 ± 7 years) who underwent transthoracic echocardiography at least ≥1 month after implantation (mean follow-up 7.8 ± 5.4 months). Results: In patients with a left ventricular dysfunction (ejection fraction, EF,

KW - CoreValve ReValving system

KW - implantation depth

KW - mitral regurgitation

UR - http://www.scopus.com/inward/record.url?scp=80053196128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053196128&partnerID=8YFLogxK

U2 - 10.1002/ccd.23045

DO - 10.1002/ccd.23045

M3 - Article

C2 - 21805556

AN - SCOPUS:80053196128

VL - 78

SP - 638

EP - 644

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 4

ER -

Access to Document

10.1002/ccd.23045